FDA Inspection 1279022 — Oklahoma Blood Institute
The FDA completed an inspection of Oklahoma Blood Institute on Jul 23, 2025 in Hot Springs, AR. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jul 23, 2025
- Fiscal Year
- 2025
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Hot Springs, AR (United States)